JP2004137196A - Emulsifying agent and cosmetic - Google Patents

Emulsifying agent and cosmetic Download PDF

Info

Publication number
JP2004137196A
JP2004137196A JP2002302998A JP2002302998A JP2004137196A JP 2004137196 A JP2004137196 A JP 2004137196A JP 2002302998 A JP2002302998 A JP 2002302998A JP 2002302998 A JP2002302998 A JP 2002302998A JP 2004137196 A JP2004137196 A JP 2004137196A
Authority
JP
Japan
Prior art keywords
component
emulsifier
lactic acid
acid bacteria
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002302998A
Other languages
Japanese (ja)
Other versions
JP4674286B2 (en
Inventor
Shigeru Sawaki
澤木 茂
Shigetoyo Sawaki
澤木茂豊
Seiji Matsukawa
松川清治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoei Kagaku Kogyo KK
Original Assignee
Kyoei Kagaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoei Kagaku Kogyo KK filed Critical Kyoei Kagaku Kogyo KK
Priority to JP2002302998A priority Critical patent/JP4674286B2/en
Publication of JP2004137196A publication Critical patent/JP2004137196A/en
Application granted granted Critical
Publication of JP4674286B2 publication Critical patent/JP4674286B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To obtain an emulsifying agent which has excellently emulsifying action and is highly safe to organisms due to low toxicity and low skin irritation, or the like, has excellent adhesivity to the skin and sense of use and is especially suitable for emulsifying a cosmetic and a medicine for external use, and the cosmetic and the medicine for external use formulated with the emulsifying agent. <P>SOLUTION: The emulsifying agent is obtained by using a lactic fermentation product prepared by fermenting one or more kinds selected from various cereals with lactic acid bacteria. The cosmetic or the medicine for external use is obtained by formulating a cosmetic or a medicine for external use with the lactic fermentation product. <P>COPYRIGHT: (C)2004,JPO

Description

【0001】
【発明の属する技術分野】
本発明は、良好な乳化作用を有し、しかも低毒性で皮膚刺激が少ないなど安全性にすぐれ、化粧料や外用医薬品、さらには食品など広汎な商品分野に於ける乳化物の調製に用いて好適な乳化剤並びにこれを配合し或いは用いてなる化粧料及び外用医薬品に関する。
【0002】
【従来の技術】
化粧料や外用医薬品の乳化には、ポリオキシエチレンアルキルエーテル、ソルビタン脂肪酸部分エステルなどの合成界面活性剤が主として用いられている。
しかしながら、合成界面活性剤の場合は、程度の差こそあれ皮膚に対する刺激作用が避けられず、このため活性剤の使用量を極力減らしたり、又場合によってはこれを用いないで乳化を行うことが試みられているが、乳化の均一性や経時安定性の点で問題を生ずるケースが多く、必ずしも満足できる結果は得られていない。
【0003】
【発明が解決しようとする課題】
これに対して、サポニン、レシチン、ステビオシド等の天然物由来成分を乳化剤として用いることにより、皮膚に対する安全性の高い乳化物を調製することが提案され、現に一部実用化されているが、乳化安定性、皮膚適用時の使用感、製造の容易さ等の点で必ずしも十分とは言い難い面があり、さらなる改善が求められている。
本発明者らは、かかる従来技術の問題点に対して、先に米を乳酸菌で醗酵して得られる乳酸菌醗酵米が、すぐれた乳化作用、乳化安定化作用と高い生体安全性を具え、化粧料等の乳化に用いて極めて有用なものであることを明らかにしたが、さらに広く天然物由来成分中に乳化剤となり得るものを見出すべく研究と探索を進めた結果、雑穀類の乳酸菌醗酵物が同様に良好な乳化作用と生体安全性とを有し、化粧料や外用医薬品、さらには食品など広汎な分野に於いて乳化剤として用い得ることを知得し、本発明を完成した。
【0004】
【課題を解決するための手段】
即ち、本発明は、雑穀類を乳酸菌で醗酵させて得られる乳酸菌醗酵物からなる乳化剤、並びに該乳酸菌醗酵物を配合してなる化粧料又は外用医薬品に関するものである。
なお、本発明に於いて化粧料とは、いわゆる化粧品のほかに医薬部外品をも含む意味で用いる。
【0005】
【発明の実施の形態】
以下、本発明について詳細に説明する。
本発明に於いて乳酸菌醗酵の被醗酵物として用いる雑穀類としては、例えば大麦、小麦、えん麦、ハト麦、カラス麦、裸麦、ライ麦などの麦類、大豆、黒大豆、小豆、いんげん豆、手亡豆、大福豆、うずら豆、えんどう豆、レンズ豆、白花豆、赤花豆、トラ豆、緑豆、ヒヨコ豆、そら豆、樹豆などの豆類、アワ、キビ、ヒエ、ソバ、アマランサス、トウモロコシなどの雑穀等が挙げられる。
それらのうちでも、乳酸菌醗酵物の乳化能或いは原料品質の安定性等の観点から、麦類としては大麦、小麦及びハト麦が、豆類としては大豆及び小豆が、又雑穀としてはアワ、キビ、ヒエ及びトウモロコシが好ましく、特に大麦、小豆、キビ及びヒエが最も好ましい。
なお、本発明に於いては、上述の雑穀類の発芽物、例えば発芽大豆、発芽大麦等を被醗酵物として用いることも可能であり、それらの発芽物によっても同じく良好な乳化作用を示す乳酸菌醗酵物を得ることができる。
本発明の乳酸菌醗酵物を調製するに当たっては、上記した雑穀類の種子のうちのいずれか一種を用いるのが一般的であるが、場合によっては二種以上の種子を混合して用いてもよい。
【0006】
雑穀類の醗酵に用いる乳酸菌としては、例えば、ラクトバチルス プランタラム(Lactobacillus plantarum)、ラクトバチルス ブレビス(L.brevis)、ラクトバチルス カゼイ(L.casei)、ラクトバチルス セロビオサス(L.cellobiosus)、ラクトバチルス バシノステルカス(L.vaccinostercus)、ストレプトコッカス フェーカリス(Streptococcus faecalis)、バチルス コアギュランス(Bacillus coagulans)等があるが、得られる乳酸菌醗酵物の乳化能等の観点からは、ラクトバチルス プランタラム(Lactobacillus plantarum)又はストレプトコッカス フェーカリス(Streptococcus faecalis)の使用が特に好ましい。
【0007】
それら乳酸菌による雑穀類の醗酵は、例えば以下のようにして行われる。
まず雑穀類の種子に、水洗、エタノール処理等適宜の手段を施して、乳酸菌醗酵の障害となる雑菌を除去する。この種子を、その1〜5倍量の精製水に浸漬し、これに糖質1〜4重量%と乳酸菌10 〜10 個/mlを添加して、嫌気性条件下、用いた乳酸菌の至適醗酵温度付近で2〜10日間醗酵を行わしめる。糖質としては、グルコース、フルクトース、ガラクトース、シュークロース等が使用されるが、なかでもフルクトースの使用が最も好ましい。また、糖質に代えて酵母エキス、麦芽エキス等を用いてもよい。
【0008】
上記の醗酵工程によって得られる雑穀類の乳酸菌醗酵物を含む液は、これをそのまま摩砕工程に付し、必要により濃縮を行って化粧料等に配合してもよいが、より一般的には乳酸菌醗酵物を醗酵液から分取し、水洗した後、要すれば水分調整を行った上、ミキサー粉砕、ロール粉砕、気流粉砕等適宜の粉砕手段を用いて粉砕し、必要ならば乾燥処理、さらには篩い分けを行って、化粧料等の乳化剤として供する。
【0009】
以上の如くして得られる雑穀類の乳酸菌醗酵物からなる本発明の乳化剤を化粧料等に配合乃至は適用する場合、該醗酵物はそれ単独で十分なる乳化力を具え、得られる乳化物は実用上十分満足し得る乳化安定性を示すが、該醗酵物にさらに増粘剤を組み合わせ用いることにより、乳化物の安定性を一層向上せしめることができる。
【0010】
ここで増粘剤としては、化粧料等に通常用いられているものが使用可能であり、具体的には、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来成分;ペクチン、ローカストビーンガム等の多糖類;キサンタンガム、トラガントガム、グアーガム等のガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体;ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸又はその誘導体、ポリグルタミン酸又はその誘導体などが挙げられる。
それらのうちでも、乳化安定性の観点、さらには本発明の乳酸菌醗酵物の特長である高い生体安全性を損なわないという観点から、特にヒアルロン酸又はその誘導体、ポリグルタミン酸又はその誘導体、キサンタンガム或いはトラガントガムの使用が好ましく、又アルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来の成分も好適に使用できる。
【0011】
それら増粘剤を併用する場合、その使用量は、用いる増粘剤の種類によっても異なるが、一般には乳酸菌醗酵物の固形分100重量部に対して、固形分で1〜100重量部の範囲、好ましくは5〜50重量部の範囲であり、かかる範囲から乳化物の用途、要求性能等を勘案して、最適のものを選択する。
【0012】
乳酸菌醗酵物との併用に当たって増粘剤は、所定の比率で予め乳酸菌醗酵物と混合して使用してもよく、又乳酸菌醗酵物を用いて化粧料等の乳化を行う際、該醗酵物の添加前又は後に、もしくは該醗酵物と同時に乳化系に添加するようにしてもよい。場合によっては乳化後に添加することもできる。
【0013】
本発明の雑穀類の乳酸菌醗酵物からなる乳化剤は、良好な乳化作用を具え、安定性に富んだ乳化物を与えると共に、低毒性で皮膚への刺激が極めて少ないなど人体に対する安全性にすぐれ、化粧料や外用医薬品、さらには食品、農薬など広汎な分野に於ける乳化物の調製に用いて有用である。
なかでも、化粧料や外用医薬品用の乳化剤として用いた場合には、乳酸菌醗酵物の有する高い保水・保湿性と皮膚に対する密着性の故に、得られる化粧料等の皮膚に対する感触、使用感が極めて良好なものとなるとの利点もある。
従って本発明によれば、上述の雑穀類の乳酸菌醗酵物を含み、乳化安定性と生体安全性、さらには使用感にすぐれた化粧料及び外用医薬品が提供される。
【0014】
雑穀類の乳酸菌醗酵物を配合してなる本発明の化粧料としては、例えば乳液、クリーム、ローション、エッセンス、パックなどの基礎化粧品;口紅、ファンデーション、リクイドファンデーション、メイクアッププレスパウダーなどのメイクアップ化粧品;洗顔料、シャンプー、リンスなどの清浄用化粧品;ヘアートリートメント、コンディショナー、ヘアークリーム、染毛料、整髪料などの頭髪化粧品;歯磨き、マウスウオッシュなどの口腔化粧品;浴剤及び各種剤形からなる医薬部外品などが挙げられる。
又、雑穀類の乳酸菌醗酵物を配合してなる本発明の外用医薬品としては、例えばクリーム、乳液、ローションなどがある。
【0015】
本発明の雑穀類の乳酸菌醗酵物を化粧料に配合する場合の配合量は、化粧料の種類等によっても異なるが、例えば、基礎化粧品、メイクアップ化粧品、頭髪化粧品及び医薬部外品の場合であれば、一般に0.5〜20重量%(乳酸菌醗酵物の固形分として。以下同じ)、好ましくは2〜10重量%の範囲、清浄用化粧品の場合であれば、一般に1〜30重量%、好ましくは5〜20重量%の範囲、又口腔化粧品の場合であれば、一般に0.5〜20重量%、好ましくは2〜10重量%の範囲である。
外用医薬品への配合量は、例えばクリームや乳液或いはローションの場合であれば、一般に0.5〜20重量%、好ましくは2〜10重量%の範囲である。
乳酸菌醗酵物の配合に当たって、増粘剤を組み合わせ用いるのであれば,乳酸菌醗酵物の配合量を上記の単独使用の場合の40〜80%に低減することができる。
【0016】
なお、本発明の雑穀類の乳酸菌醗酵物を化粧料等に配合するに当たって、該乳酸菌醗酵物に予め親水性物質、特に糖類及びグリコール類から選ばれた1種又は2種以上を混和した場合、該乳酸菌醗酵物の水に対する馴染み・分散性が改善され、化粧料等への配合が容易となって好ましい。
【0017】
この場合糖類としては、例えばグルコース、フルクトース、アラビノース、ガラクトースなどの単糖類;シュークロース、ラクトース、マルトース、トレハロースなどの二糖類;フラクトオリゴ糖、キシロオリゴ糖、マルトオリゴ糖などの少糖類;ソルビトール、マルチトール、キシリトールなどの糖アルコール類等が使用できる。
【0018】
又グリコール類としては、例えばグリセリン、プロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコールなどがある。
【0019】
それら糖類及び/又はグリコール類(以下、混和成分ということがある)のうちでも、乳酸菌醗酵物の水に対する馴染み・分散性の改善効果の点からは、糖類の使用が好ましく、糖類のうちでも糖アルコール類の使用が最も好ましい。。
【0020】
又、分散性改善効果は、乳酸菌醗酵物と糖類及び/又はグリコール類との混和物が水もしくは液体状物質によって湿潤状態にあるとき、より効果的に発現されることから、混和成分として糖類を用いる場合には、それらを水溶液の形で乳酸菌醗酵物に配合する方法等によって、得られる混和物を、水分率が10〜40重量%、特に15〜30重量%の範囲の湿潤状態とすることが好ましい。
一方、常温で液体状であるグリセリン、1,3−ブチレングリコールなどのグリコール類を使用する場合は、グリコール自身の特性に基づいて混和物を湿潤状態とすることが可能であり、水の使用は必ずしも必要でないが、場合によってはこれを併用してもよい。
【0021】
乳酸菌醗酵物に対する糖類或いはグリコール類の配合量は、それら成分のいずれの場合も、乳酸菌醗酵物(固形分)100重量部に対して、固形分で一般に5〜50重量部、好ましくは10〜40重量部の範囲である。
【0022】
乳酸菌醗酵物と糖類及び/又はグリコール類との混和物を調製する方法としては、乳酸菌醗酵物に所定量の混和成分を添加し、適宜の混合手段を用いて均一な混和物とする方法など常法に従って行えばよく特に制限はないが、混和成分として単糖、糖アルコールなど常温で固体状の物質を用いる場合には、混和物の分散性改善効果をより効果的に発現せしめるため、前記した通り、それら混和成分を水溶液の形で乳酸菌醗酵物と混和するようにするか、もしくは場合によっては粉末状のまま混和した後水を添加することにより、混和物の水分率を所望の値に調整することが好ましい。
【0023】
以上の如くして得られる混和物を化粧料等に配合する場合、その水に対する馴染み・分散性改善の結果として、配合作業性さらには得られる製品の均質性が大幅に改善されることは既に述べた通りであるが、本発明の雑穀類の乳酸菌醗酵物は、乳酸菌醗酵の特性上、水に分散・溶解せしめた時酸性を示すため、化粧料等への配合に当たって、場合によってはなお中和工程が必要となるケースも考えられる。
かかる工程上の煩雑さを解消し、作業性、取り扱い性のより改良された混和物とするため、これにさらにアルカリ性物質を配合するようにしてもよい。
【0024】
この場合、アルカリ性物質としては、例えば水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、水酸化マグネシウムなどのアルカリ金属或いはアルカリ土類金属の水酸化物;炭酸、クエン酸、リン酸などの弱酸のアルカリ金属塩;エタノールアミン、ジエタノールアミン、トリエタノールアミン、イソプロパノールアミンなどのアミン類;アルギニン、リジン、ヒスチジンなどの塩基性アミノ酸類;アンモニア水、アミノメチルプロパノール、アミノメチルプロパンジオールなどが挙げられる。
【0025】
これらアルカリ性物質の配合量は、用いるアルカリ性物質の種類等によって異なるが、一般には、組成物の10重量%水分散液或いは水溶液の示すpHが5.5〜7.5の範囲となるような量とするのがよい。
【0026】
本発明の雑穀類の乳酸菌醗酵物を配合した化粧料や外用医薬品を調製する場合、その構成成分としては、通常化粧料等に用いられる成分、例えば油性成分、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、抗酸化剤、色素、香料、生理活性成分、薬剤等を適宜使用することができる。又、必要ならば界面活性剤を併用してもよい。
【0027】
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアーバター、ティーツリー油、アボカド油、マカデミアナッツ油、植物由来スクワランなどの植物由来の油脂類;ミンク油、タートル油などの動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリンなどのロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、cis−11−エイコセン酸などの脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコールなどの高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)などの合成エステル類及び合成トリグリセライド類等が挙げられる。
【0028】
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボン酸ナトリウム等があり、さらにトレハロース等の糖類、乳酸菌醗酵米、ヒアルロン酸及びその誘導体、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、ビャッキュウ抽出物、海藻抽出物、魚介類由来コラーゲン及びその誘導体、各種アミノ酸及びそれらの誘導体が挙げられる。
【0029】
増粘剤としては、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻或いは紅藻由来成分、ビャッキュウ抽出物、ペクチン、ローカストビーンガム、アロエ多糖体等の多糖類、キサンタンガム、トラガントガム、グアーガム等のガム類、カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体、ポリグルタミン酸及びその誘導体等が挙げられる。
【0030】
防腐・殺菌剤としては、例えば尿素;パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)、1,2−ペンタンジオール、各種精油類、樹皮乾留物等がある。
【0031】
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー、シルクパウダー、穀類(米、麦、トウモロコシ、キビなど)のパウダー、豆類(大豆、小豆など)のパウダー等がある。
【0032】
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2−エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−ターシャリーブチル−4−メトキシベンゾイルメタン、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。
【0033】
抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体、各種ポリフェノール類、ビャッキュウ抽出物、イネ抽出物等がある。
【0034】
生理活性成分としては、例えば美白成分として、t−シクロアミノ酸誘導体、コウジ酸及びその誘導体、アスコルビン酸及びその誘導体、アルブチン及びその誘導体、エラグ酸及びその誘導体、レゾルシノール誘導体、ソウハクヒ抽出物、ユキノシタ抽出物、米糠抽出物、米糠抽出物の加水分解物、白芥子加水分解抽出物、ムラサキシキブ抽出物、コンブ等の海藻の抽出物、アマモ等の海草の抽出物、リノール酸及びその誘導体もしくは加工物(例えばリポソーム化リノール酸など)、2,5−ジヒドロキシ安息香酸誘導体等が、皮膚老化防止・肌荒れ改善成分として、動物又は魚由来のコラーゲン、ニコチン酸及びその誘導体、グリチルリチン酸及びその誘導体(ジカリウム塩等)、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、ビタミンE及びその誘導体、アラントイン、α−ヒドロキシ酸類、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、ゲンチアナエキス、甘草エキス、ハトムギエキス、カミツレエキス、ニンジンエキス、アロエエキスなどの生薬抽出エキス、米抽出物加水分解物、米糠抽出物加水分解物、米醗酵エキス、ミツイシコンブ抽出物、アマモ等の海草の抽出物、ソウハクヒエキス等がある。
【0035】
上記のコウジ酸誘導体としては、例えばコウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレートなどのコウジ酸エステル類、コウジ酸エーテル類、コウジ酸グルコシドなどのコウジ酸糖誘導体等が、アスコルビン酸誘導体としては、例えばL−アスコルビン酸−2−リン酸エステルナトリウム、L−アスコルビン酸−2−リン酸エステルマグネシウム、L−アスコルビン酸−2−硫酸エステルナトリウム、L−アスコルビン酸−2−硫酸エステルマグネシウムなどのアスコルビン酸エステル塩類、L−アスコルビン酸−2−グルコシド(2−O−α−D−グルコピラノシル−L−アスコルビン酸)、L−アスコルビン酸−5−グルコシド(5−O−α−D−グルコピラノシル−L−アスコルビン酸)などのアスコルビン酸糖誘導体、それらアスコルビン酸糖誘導体の6位アシル化物(アシル基は、ヘキサノイル基、オクタノイル基、デカノイル基など)、L−アスコルビン酸テトライソパルミチン酸エステル、L−アスコルビン酸テトララウリン酸エステルなどのL−アスコルビン酸テトラ脂肪酸エステル類等が、レゾルシノール誘導体としては、例えば4−n−ブチルレゾルシノール、4−イソアミルレゾルシノール等が、2,5−ジヒドロキシ安息香酸誘導体としては、例えば2,5−ジアセトキシ安息香酸、2−アセトキシ−5−ヒドロキシ安息香酸、2−ヒドロキシ−5−プロピオニルオキシ安息香酸等が、ニコチン酸誘導体としては、例えばニコチン酸アミド、ニコチン酸ベンジル等が、ビタミンE誘導体としては、例えばビタミンEニコチネート、ビタミンEリノレート等が、α−ヒドロキシ酸としては、例えば乳酸、リンゴ酸、コハク酸、クエン酸、α−ヒドロキシオクタン酸等がある。
【0036】
薬剤としては、アミノ安息香酸エチル、インドメタシン、ヘパリンナトリウム、サリチル酸メチルなどの消炎鎮痛・鎮痒剤;ヒドロコルチゾン、デキサメタゾン、フルオシノロンアセトニド、プレドニゾロンなどの副腎皮質ホルモン抗炎症剤;塩化ベンザルコニウム、塩化ベンゼトニウム、クロルヘキシジン、スルファジアジンなどの殺菌剤;エリスロマイシン、テトラサイクリン、クロラムフェニコール、トリコマイシンなどの抗生物質殺菌剤;クロトリマゾール、トルナフテート、硝酸ミコナゾール、ケトコナゾールなどの抗真菌剤;ジフェンヒドラミン、マレイン酸クロルフェニラミン、塩酸イソチペンジル、フマル酸クレマスチンなどの抗ヒスタミン剤;尿素、サリチル酸、ビタミンA、ビタミンE、ビタミンC、ビタミンBなどの肌荒れ改善剤等が挙げられる
【0037】
なお、前述の通り、界面活性剤は必ずしもこれを併用する必要はないが、仮に併用する場合には、ショ糖脂肪酸エステル、レシチン及びその誘導体、酵素処理ステビアなどの生体安全性にすぐれた活性剤を少量用いることが好ましい。
【0038】
次に、実施例、処方例(化粧料及び外用医薬品の実施例)及び試験例によって本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下に於いて、部はすべて重量部を、また%はすべて重量%を意味する。
【0039】
実施例1.乳化剤の調製(1)
ハト麦1Kgを70%エタノールに一晩浸漬して殺菌し、次いで濾過によりハト麦を分取した後、これにボイル殺菌した水2Lを加えて洗浄する操作を3回繰り返して、エタノールを十分に除去した。
殺菌したハト麦に、ボイル殺菌した0.1%酵母エキス溶液3Lを加えた後、これに、予めGYP培地で前培養(37℃、3日間)しておいた乳酸菌(S.faecalis)培養液を、乳酸菌の濃度が10個/0.1%酵母エキス1mlとなる量だけ加え、窒素雰囲気下に37℃で3日間培養した。
培養終了後、金網で粗ろ過してハト麦の乳酸菌醗酵物を分取し、これを流水で洗浄して付着した培養液を十分に洗い流した後、60℃、通風の条件下に、水分率が約15%以下となるまで乾燥させた。次に、この乾燥物をミキサー粉砕した後篩い分け(90μm、166メッシュ)して、ハト麦の乳酸菌醗酵物を微粉末として得た(収量920g、水分率12.5%)。
【0040】
実施例2.乳化剤の調製(2)
乳酸菌としてS.faecalisに代えてL.plantalumを用いるほかは実施例1と同様の操作を行い、ハト麦の乳酸菌醗酵物を微粉末として得た(収量910g、水分率12.4%)。
【0041】
実施例3.乳化剤の調製(3)
ハト麦に代えて大麦を用いるほかは実施例1と同様の操作を行い、大麦の乳酸菌醗酵物を微粉末として得た(収量580g、水分率12.0%)。
【0042】
実施例4.乳化剤の調製(4)
ハト麦に代えてアワを用いるほかは実施例1と同様の操作を行い、アワの乳酸菌醗酵物を微粉末として得た(収量880g、水分率12.8%)。
【0043】
実施例5.乳化剤の調製(5)
ハト麦に代えてキビを用いるほかは実施例1と同様の操作を行い、キビの乳酸菌醗酵物を微粉末として得た(収量890g、水分率12.4%)。
【0044】
実施例6.乳化剤の調製(6)
ハト麦に代えてヒエを用いるほかは実施例1と同様の操作を行い、ヒエの乳酸菌醗酵物を微粉末として得た(収量900g、水分率12.0%)。
【0045】
実施例7.乳化剤の調製(7)
ハト麦に代えて大豆を用いるほかは実施例1と同様の操作を行い、大豆の乳酸菌醗酵物を微粉末として得た(収量920g、水分率13.2%)。
【0046】
実施例8.乳化剤の調製(8)
ハト麦に代えて小豆を用いるほかは実施例1と同様の操作を行い、小豆の乳酸菌醗酵物を微粉末として得た(収量780g、水分率12.5%)。
【0047】
実施例9.乳化剤の調製(9)
大豆を水洗し、3倍量の水に一晩浸漬した後、水切りした。これを湿潤状態に30℃で2日間保持して発芽させ、発芽した大豆を60℃で一晩乾燥した。
この乾燥発芽大豆1Kgを70%エタノールに一晩浸漬して殺菌し、次いで濾過により発芽大豆を分取した後、これにボイル殺菌した水2Lを加えて洗浄する操作を3回繰り返して、エタノールを充分に除去した。
殺菌した発芽大豆に、ボイル殺菌した0.1%酵母エキス溶液3Lを加えた後、これに、予めGYP培地で前培養(37℃、3日間)しておいたた乳酸菌(S.faecalis)培養液を、乳酸菌の濃度が10個/0.1%酵母エキス1mlとなる量だけ加え、窒素雰囲気下に37℃で3日間培養した。
培養終了後、金網で粗ろ過して発芽大豆の乳酸菌醗酵物を分取し、これを流水で洗浄して付着した培養液を十分に洗い流した後、60℃、通風の条件下に、水分率が約15%以下となるまで乾燥させた。次に、この乾燥物をミキサー粉砕した後篩い分け(90μm、166メッシュ)して、発芽大豆の乳酸菌醗酵物を微粉末として得た(収量890g、水分率13.5%)。
【0048】
実施例10.乳化剤の調製(10)
大豆に代えて大麦を用いるほかは実施例9と同様の操作を行い、発芽大麦の乳酸菌醗酵物を微粉末として得た(収量880g、水分率12.8%)。
【0049】
実施例11.乳化剤組成物の調製(1)
実施例1と同様に操作して得られたハト麦の乳酸菌醗酵物の微粉末800gにマルチトール液(70%マルチトール水溶液)200gを加え、練合機で練合・混和して均一な混和物を得た(水分率14.6%)。
【0050】
実施例12.乳化剤組成物の調製(2)
マルチトール液200gに代えてグリセリン200gを用いるほかは実施例11と同様に操作して均一な混和物を得た(水分率12.4%)。
【0051】
実施例13.乳化剤組成物の調製(3)
実施例1と同様に操作して得られたハト麦の乳酸菌醗酵物の微粉末785gにマルチトール液200gとアルギニン15gを加え、練合機で練合・混和して均一な混和物を得た(水分率15.1%)。
【0052】
処方例1.クリーム
[A成分]                              部
流動パラフィン                       5.0
オリーブ油                         4.0
パラフィン                         5.0
セタノール                         2.0
ブチルパラベン                       0.1
[B成分]
実施例1の乳化剤                      5.0
1,3−ブチレングリコール                10.0
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して均質なクリームを得た。
【0053】
処方例2.乳液
[A成分]                              部
流動パラフィン                       5.0
オリーブ油                         4.0
スクワラン                         5.0
ブチルパラベン                       0.1
[B成分]
実施例1の乳化剤                      5.0
1,3−ブチレングリコール                10.0
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して均質な乳液を得た。
【0054】
処方例3.化粧水
[A成分]                              部
オリーブ油                         1.0
ブチルパラベン                       0.1
[B成分]
実施例1の乳化剤                      1.0
エタノール                         5.0
グリセリン                         5.0
1,3−ブチレングリコール                 5.0
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して乳白色の化粧水を得た。
【0055】
処方例4.エッセンス
[A成分]                              部
オリーブ油                         1.0
ブチルパラベン                       0.1
[B成分]
実施例1の乳化剤                      2.0
エタノール                         5.0
ヒアルロン酸                        0.3
1,3−ブチレングリコール                 5.0
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して乳白色のエッセンスを得た。
【0056】
処方例5.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例2の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0057】
処方例6.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例3の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0058】
処方例7.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例4の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0059】
処方例8.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例5の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0060】
処方例9.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例6の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0061】
処方例10.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例7の混和物5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0062】
処方例11.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例8の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0063】
処方例12.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例9の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0064】
処方例13.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例10の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0065】
処方例14.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例11の乳化剤組成物6.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0066】
処方例15.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例12の乳化剤組成物6.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0067】
処方例16.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例13の乳化剤組成物6.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0068】
処方例17.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例1の乳化剤2.0部とキサンタンガム0.5部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0069】
処方例18.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例1の乳化剤2.0部とヒアルロン酸0.5部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0070】
処方例19.ヘアートリートメント
[A成分]                              部
塩化ステアリルトリメチルアンモニウム            5.0
モノステアリン酸グリセリル                 1.0
セタノール                         3.0
オクチルドデカノール                    2.0
[B成分]
実施例1の乳化剤                      5.0
1,3−ブチレングリコール                 5.0
加水分解コラーゲン末                    0.5
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却した。
【0071】
処方例20.ヘアークリーム
[A成分]                              部
スクワラン                        15.0
ワセリン                         15.0
ミツロウ                          2.0
メチルパラベン                       適 量
[B成分]
グリセリン                         3.0
1,3−ブチレングリコール                 3.0
キサンタンガム                       0.1
実施例2の乳化剤                      5.0
ポリオキシエチレン硬化ヒマシ油               3.0
精製水                   全量が100部となる量
[C成分]
香料                            適 量
A成分及びB成分をそれぞれ80℃に加温溶解後、両成分を合してヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを攪拌しながら冷却し、50℃でC成分を加えてさらに30℃まで冷却した。
【0072】
処方例21.染毛剤・染料ベース
[A成分]                              部
酸化染料                          3.5
オレイン酸                        20.0
ステアリン酸ジエタノールアミド               3.0
ポリオキシエチレン(50)オレイルエーテル         1.0
[B成分]
実施例3の乳化剤                      3.0
1,3−ブチレングリコール                10.0
イソプロパノール                     10.0
アンモニア水(28%)                  10.0
亜硫酸ナトリウム                      0.5
精製水                   全量が100部となる量
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを攪拌しながら30℃以下まで冷却した。
【0073】
処方例22.リクイドファンデーション
[A成分]                              部
ステアリン酸                        2.5
セタノール                         0.5
モノステアリン酸グリセリル                 2.0
ラノリン                          2.0
スクワラン                         3.0
ミリスチン酸イソプロピル                  8.0
プロピルパラベン                      0.1
[B成分]
実施例1の乳化剤                      3.0
キサンタンガム                       0.3
1,3−ブチレングリコール                 5.0
トリエタノールアミン                    1.0
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
酸化チタン                         8.0
タルク                           4.0
着色顔料                          適 量
[D成分]
香料                            0.3
C成分を混合し、粉砕機で粉砕した。B成分を混合し、これに粉砕したC成分を加え、コロイドミルで均一分散させた。A成分及び均一分散させたB、C成分をそれぞれ80℃に加温後、B、C成分にA成分を攪拌しながら加え、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを50℃まで冷却した後、D成分を加えて攪拌混合し、さらに攪拌しながら30℃以下まで冷却した。
【0074】
処方例23.クリームファンデーション
[A成分]                              部
ステアリン酸                        5.0
セタノール                         2.0
モノステアリン酸グリセリル                 3.0
流動パラフィン                       5.0
スクワラン                         3.0
ミリスチン酸イソプロピル                  8.0
プロピルパラベン                      0.1
[B成分]
実施例5の乳化剤                      3.0
ソルビトール                        3.0
1,3−ブチレングリコール                 5.0
トリエタノールアミン                    1.5
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
酸化チタン                         8.0
タルク                           2.0
カオリン                          5.0
ベントナイト                        1.0
着色顔料                          適 量
[D成分]
香料                            0.3
C成分を混合し、粉砕機で粉砕した。B成分を混合し、これに粉砕したC成分を加え、コロイドミルで均一分散させた。A成分及び均一分散させたB、C成分をそれぞれ80℃に加温後、B、C成分にA成分を攪拌しながら加え、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを50℃まで冷却した後、D成分を加えて攪拌混合し、さらに攪拌しながら30℃以下まで冷却した。
【0075】
処方例24.クリームリンス
[A成分]                              部
ポリオキシエチレン(10)硬化ヒマシ油           1.0
塩化ジステアリルジメチルアンモニウム            1.5
塩化ステアリルトリメチルアンモニウム            2.0
2−エチルヘキサン酸グリセリル               1.0
セタノール                         3.2
ステアリルアルコール                    1.0
メチルパラベン                       0.1
[B成分]
実施例1の乳化剤                     15.0
1,3−ブチレングリコール                 5.0
精製水                   全量が100部となる量
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却した。
【0076】
処方例25.クリームシャンプー
[A成分]                              部
N−ヤシ油脂肪酸メチルタウリンナトリウム         10.0
ポリオキシエチレン(3)アルキルエーテル硫酸ナトリウム   20.0
ラウリルジメチルアミノ酢酸ベタイン            10.0
ヤシ油脂肪酸ジエタノールアミド               4.0
メチルパラベン                       0.1
[B成分]
クエン酸                          0.1
実施例6の乳化剤                     15.0
1,3−ブチレングリコール                 2.0
精製水                   全量が100部となる量
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却した。
【0077】
処方例26.ボディシャンプー
[A成分]                              部
N−ラウロイルメチルアラニンナトリウム          25.0
ヤシ油脂肪酸カリウム液(40%)             26.0
ヤシ油脂肪酸ジエタノールアミド               3.0
メチルパラベン                       0.1
[B成分]
実施例1の乳化剤                     10.0
1,3−ブチレングリコール                 2.0
精製水                   全量が100部となる量
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却した。
【0078】
処方例27.練り歯磨き
[A成分]                              部
第二リン酸カルシウム・2水塩                60.0
無水ケイ酸                         2.0
香料                            適 量
[B成分]
グリセリン                        10.0
1,3−ブチレングリコール                 5.0
実施例8の乳化剤                      5.0
ラウリル硫酸ナトリウム                   2.0
カラギーナン                        0.3
メチルパラベン                       適 量
サッカリンナトリウム                    0.1
精製水                   全量が100部となる量
B成分を混合し、80℃に加温溶解後30℃まで冷却した。これにA成分を加えて充分に練合した後、減圧脱泡した。
【0079】
処方例28.乳液
[A成分]                              部
流動パラフィン                       5.0
オリーブ油                         4.0
スクワラン                         5.0
ブチルパラベン                       0.1
[B成分]
実施例1の乳化剤                      5.0
1,3−ブチレングリコール                10.0
コウジ酸                          2.0
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して均質な乳液を得た。
【0080】
処方例29.乳液
処方例28のB成分中、コウジ酸2.0部に代えてL−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.2部を用いるほかは処方例28と同様にして乳液を得た。
【0081】
処方例30.乳液
処方例28のB成分中、コウジ酸2.0部に代えてL−アスコルビン酸−2−リン酸エステルマグネシウム3.0部を用いるほかは処方例28と同様にして乳液を得た。
【0082】
処方例31.乳液
処方例28のB成分中、コウジ酸2.0部に代えてアルブチン2.0部を用いるほかは処方例28と同様にして乳液を得た。
【0083】
処方例32.乳液
[A成分]                              部
流動パラフィン                       5.0
オリーブ油                         4.0
スクワラン                         5.0
ジイソプロピルアミンジクロロアセテート           0.5
ブチルパラベン                       0.1
[B成分]
実施例3の乳化剤                      3.0
1,3−ブチレングリコール                10.0
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して乳液を得た。
【0084】
処方例33.乳液
[A成分]                              部
流動パラフィン                       5.0
オリーブ油                         4.0
スクワラン                         5.0
γ−アミノ−β−ヒドロキシ酪酸               0.5
ブチルパラベン                       0.1
[B成分]
実施例2の乳化剤                      3.0
1,3−ブチレングリコール                10.0
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して均質な乳液を得た。
【0085】
処方例34.浴剤
[A成分]                              部
エタノール                         5.0
メチルパラベン                       0.2
黄色4号                          0.1
香料                            1.5
[B成分]
1,3−ブチレングリコール                 5.0
実施例1の乳化剤                     10.0
精製水                   全量が100部となる量
[C成分]
リン酸水素二ナトリウム                    適量
B成分を85℃まで加温して溶解し、室温まで冷却した後、これにA成分を混合溶解した液を加え、次いでC成分を添加してpHを7とした。
【0086】
処方例35.消炎鎮痛剤
[A成分]                              部
流動パラフィン                       5.0
オリーブ油                         4.0
パラフィン                         5.0
セタノール                         2.0
インドメタシン                       1.0
ブチルパラベン                       0.1
[B成分]
実施例1の乳化剤                      5.0
1,3−ブチレングリコール                10.0
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して消炎鎮痛剤(クリーム)を得た。
【0087】
処方例36.抗炎症剤
[A成分]                              部
流動パラフィン                       5.0
オリーブ油                         4.0
パラフィン                         5.0
セタノール                         2.0
デキサメタゾン                       0.2
ブチルパラベン                       0.1
[B成分]
実施例1の乳化剤                      5.0
1,3−ブチレングリコール                10.0
メチルパラベン                       0.1
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して抗炎症剤(クリーム)を得た。
【0088】
処方例37.抗真菌剤
[A成分]                              部
流動パラフィン                       5.0
オリーブ油                         4.0
スクワラン                         5.0
トルナフテート                       1.0
ブチルパラベン                       0.1
[B成分]
実施例2の乳化剤                      3.0
1,3−ブチレングリコール                10.0
精製水                   全量が100部となる量
[C成分]
香料                            0.3
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して抗真菌剤(乳液)を得た。
【0089】
試験例1.乳化作用(その1)
本発明の雑穀類の乳酸菌醗酵物からなる乳化剤と、比較のため雑穀類をそのままミキサー粉砕し篩い分け(90μm、166メッシュ)して得られた微粉末について乳化作用を調べた。
[試料]
(1)本発明試料:実施例1、3、4、5、6、7及び8の各乳化剤
(2)比較試料 :ハト麦、大麦、アワ、キビ、ヒエ、大豆及び小豆の各微粉末
[試験方法]
表1に示す成分組成からなる乳化物を調製し、それらの乳化直後の状態と経時変化を観察した。なお、実施例7及び8の乳化剤並びに大豆と小豆の微粉末については、表1の組成Aを用い、その他の試料については組成Bを用いた。
【0090】
【表1】

Figure 2004137196
【0091】
即ち、成分4を成分3に溶解し、これに成分2及び成分5を加えて混合し、80℃に加熱した。これを、成分1の油性成分を80℃に加熱したものに加え、5000rpm×2分間の条件でホモジナイズした後、攪拌下に水冷して室温まで冷却した。ここに得られた乳化物をそれぞれ50mlのスクリュウ瓶に入れ、調製直後の乳化状態と、室温又は50℃に3カ月間保存した時の乳化状態の経時変化を目視観察し、以下の基準により評価した。
◎ :良好
○ :1カ月以上経過後に極く僅かに分離が認められる
△ :2週間〜1カ月経過後に僅かに分離が認められる
× :1週間以内に完全分離する
なお、比較試料のハト麦微粉末、アワ微粉末及び大豆微粉末の場合には、いずれも乳化物調製直後に油浮きが認められ、乳化状態は不良であった。
【0092】
[結果]
結果を表2に示す。
【表2】
Figure 2004137196
【0093】
表2に示す通り、本発明の雑穀類の乳酸菌醗酵物からなる乳化剤は、いずれもすぐれた乳化作用を有し、長期間安定な乳化物を与える。これに対して、乳酸菌醗酵を行っていない雑穀類の微粉末によっては、安定な乳化物は得られない。
【0094】
試験例2.乳化作用(その2)
乳酸菌醗酵物に増粘剤を併用した場合の乳化安定性への影響を調べた。
[試験方法]
表3に示す成分組成(単位:部)からなる3種の乳化物を調製し、それらの経時変化を観察した。
【0095】
【表3】
Figure 2004137196
【0096】
即ち、成分4を成分3に溶解し、これに成分5のいずれかを加えて混合した。別に、成分2と6の混合物及び成分1をそれぞれ80℃に加温後、成分1に成分2と6の混合物を加え、ヒスコトロン(5000rpm)で2分間ホモジナイズした。これに上記の成分3、4、5の混合物を加え、ヒスコトロン(5000rpm)でさらに1分間ホモジナイズした後、攪拌しながら室温まで水冷した。ここに得られた乳化物をそれぞれ50mlのスクリュウ瓶に入れ、調製直後の乳化状態と、室温又は50℃に3カ月間保存した時の乳化状態の経時変化を目視観察し、試験例1と同様の基準に従って評価した。
【0097】
[結果]
結果を表4に示す。
【表4】
Figure 2004137196
【0098】
表4の結果から、乳酸菌醗酵物に増粘剤を併用した場合、得られる乳化物の安定性が一層向上することが判る。
【0099】
試験例3.皮膚刺激性
本発明の乳酸菌醗酵物の皮膚刺激性を、化粧料の乳化剤として汎用されている成分のそれと比較した。
[試料]
下記の成分を、各々日局親水ワセリンに5%の濃度となるように練合したものを試料として用いた。
(1)実施例1の乳化剤(本発明試料)
(2)ポリオキシエチレン(20)ソルビタンモノオレエート(比較試料a)
(3)親油型モノステアリン酸グリセリン(比較試料b)
【0100】
[試験方法]
年齢20〜50歳の成人男子5名を被験者とし、各々の上腕部内側をエタノールで拭って皮脂を除去し、該部位に、フィンチャンバーのアルミ板に各々の試料0.2gを塗布したものを貼付した。24時間後にフィンチャンバーを除去し、皮膚刺激の程度をつぎに述べる方法並びに基準により判定した。
【0101】
[判定]
パッチ除去後1時間後、24時間後及び48時間後に、貼付部位の紅斑及び浮腫の状況を、以下の「ドレイズ法による皮膚刺激性判定基準」に基づき目視判定し、被験者5名の平均値を求めた。
(紅斑)
スコア   皮膚の状態
0  : 紅斑なし
1  : 極く軽度の紅斑
2  : 明らかな紅斑
3  : 中程度から強い紅斑
4  : 深紅色の強い紅斑に軽い痂皮形成
(浮腫)
スコア   皮膚の状態
0  : 浮腫なし
1  : 極く軽度の浮腫
2  : 明らかな浮腫(周囲と明らかに区別可能)
3  : 中程度の浮腫(1mm以上の盛り上がり)
4  : 強い浮腫(さらに周囲にも広がり)
【0102】
[結果]
結果を表5に示す。
【表5】
Figure 2004137196
【0103】
本試験で比較試料として用いたa、bの活性剤は、比較的安全性が高いところから、化粧料の乳化に汎用されているものであるが、表5の結果から明らかな通り、本発明の乳酸菌醗酵物からなる乳化剤は、それらの乳化剤よりもさらに皮膚刺激性が少なく、安全性に極めてすぐれている。
【0104】
試験例4.モニターテスト
下記の各試料について、モニターテストにより使用感と安全性(皮膚刺激性)を評価した。
[試料]
(1) 処方例2の乳液(本発明乳液)
(2) 処方例2に於いて、実施例1の乳化剤5.0部に代えてポリオキシエチレン(20)ソルビタンモノオレエート2.0部を用いるほかは処方例2と同様にして得られた乳液(比較乳液)
【0105】
[試験方法]
無作為に抽出した年齢18〜50歳の女性20名を被験者とし、各乳液を1日2回(朝、晩)、5日間左上腕部にそれぞれ塗布した時の使用感及び皮膚刺激性を、下記の各項目について評価した。
(使用感)
イ.手に取った感触
ロ.塗布時の伸び
ハ.塗布時のなめらかさ
ニ.浸透性(浸透感)
ホ.塗布後の感触
(皮膚刺激性)
ヘ.塗布時の刺激
ト.塗布後の刺激
評価は、使用感については5段階評価(A:良い、B:やや良い、C:普通、D:やや悪い、E:悪い)によって、又皮膚刺激性については3段階評価(A:刺激なし、B:違和感あり、C:刺激あり)によってそれぞれ行った。
【0106】
[結果]
結果を表6及び表7に示す。
【表6】
Figure 2004137196
【0107】
【表7】
Figure 2004137196
【0108】
表6及び表7に示す通り、本発明の乳酸菌醗酵物からなる乳化剤を使用して調製された乳液は、使用感に於いて高い評価を得ており、又皮膚刺激性も認められなかった。
これに対して、合成界面活性剤を用いて得られた比較乳液は、使用感に於いて劣るだけでなく、若干の皮膚刺激性も認められた。
【発明の効果】
雑穀類の乳酸菌醗酵物からなる本発明の乳化剤は、良好な乳化力を具えると共に、低毒性でかつ皮膚刺激が極めて少ないなど人に対する安全性にすぐれ、化粧料、外用医薬品、食品など広汎な分野に於ける乳化物の調製に用いて有用である。 なかでも、化粧料や外用医薬品の乳化剤として用いた場合には、該乳酸菌醗酵物の有する高い保湿・保水能と皮膚に対する密着性の故に、得られる化粧料、外用医薬品は、皮膚に対する感触、使用感にすぐれたものとなる。
従って、本発明によれば又、上記の乳酸菌醗酵物を含んでなり、乳化安定性と生体安全性、さらには使用感の良好な化粧料及び外用医薬品が提供される。[0001]
TECHNICAL FIELD OF THE INVENTION
INDUSTRIAL APPLICABILITY The present invention has a good emulsifying action, and is excellent in safety such as low toxicity and little skin irritation, and is used for preparation of emulsions in a wide range of commercial fields such as cosmetics and external medicines, and foods. The present invention relates to a suitable emulsifier and cosmetics and external medicines containing or using the same.
[0002]
[Prior art]
Synthetic surfactants such as polyoxyethylene alkyl ethers and sorbitan fatty acid partial esters are mainly used for emulsification of cosmetics and external medicines.
However, in the case of synthetic surfactants, irritation to the skin is inevitable to a greater or lesser degree.Therefore, it is possible to reduce the amount of active agents used as much as possible or to emulsify without using them in some cases. Although attempts have been made, there are many cases where problems occur in terms of uniformity of emulsification and stability over time, and satisfactory results have not always been obtained.
[0003]
[Problems to be solved by the invention]
On the other hand, it has been proposed to prepare a highly safe emulsion for the skin by using components derived from natural products such as saponin, lecithin and stevioside as an emulsifier, and some of them have been practically used. There are aspects that are not always sufficient in terms of stability, use feeling when applied to the skin, ease of production, and the like, and further improvement is required.
In order to solve the problems of the prior art, the present inventors have found that lactic acid bacteria-fermented rice obtained by first fermenting rice with lactic acid bacteria has excellent emulsifying action, emulsifying stabilizing action and high biosafety, Lactic acid bacteria fermentation products of cereals as a result of research and exploration to find out what could become an emulsifier in components derived from natural products. Similarly, they have good emulsifying action and biosafety, and have learned that they can be used as emulsifiers in a wide variety of fields such as cosmetics, external medicines, and foods, thus completing the present invention.
[0004]
[Means for Solving the Problems]
That is, the present invention relates to an emulsifier comprising a fermented product of lactic acid bacteria obtained by fermenting cereals with lactic acid bacteria, and a cosmetic or topical medicine containing the fermented product of lactic acid bacteria.
In addition, in the present invention, the cosmetic is used in a sense that it includes quasi-drugs in addition to so-called cosmetics.
[0005]
BEST MODE FOR CARRYING OUT THE INVENTION
Hereinafter, the present invention will be described in detail.
Examples of the cereals used as the fermented product of the lactic acid bacteria fermentation in the present invention include barley, wheat, oats, barley, oats, oats, rye, and so on, soybeans, black soybeans, red beans, green beans, hand-held beans. , Soybeans, quail beans, peas, peas, lentils, white flowers, red flowers, tiger beans, green beans, chickpeas, broad beans, tree beans, etc., millet, millet, millet, buckwheat, amaranth, corn, etc. And the like.
Among them, from the viewpoint of the emulsifying ability of the fermented lactic acid bacteria or the stability of the raw material quality, etc., barley, wheat and pigeon barley, soybeans and red beans as beans, millet, millet, millet, Millet and corn are preferred, especially barley, red beans, millet and millet are most preferred.
In the present invention, germinated products of the above-mentioned cereals, such as germinated soybeans, germinated barley, etc., can also be used as fermented products. Fermented products can be obtained.
In preparing the fermented product of lactic acid bacteria of the present invention, it is general to use any one of the seeds of the above-described cereals, but in some cases, a mixture of two or more seeds may be used. .
[0006]
Examples of lactic acid bacteria used for fermentation of cereals include Lactobacillus plantarum, Lactobacillus brevis, Lactobacillus casei, Lactobacillus cellobiosas, and Lactobacillus cellobiosas. There are L. vacinostercus, Streptococcus faecalis, Bacillus coagulans, and the like. From the viewpoint of the emulsifying ability of the resulting lactic acid bacteria fermented product, Lactobacillus sp. (Str Use of ptococcus faecalis) are particularly preferred.
[0007]
Fermentation of cereals by these lactic acid bacteria is performed, for example, as follows.
First, seeds of cereals are subjected to appropriate means such as washing with water and ethanol treatment to remove germs which hinder lactic acid bacteria fermentation. The seeds are immersed in 1 to 5 times the amount of purified water, and 1 to 4% by weight of saccharide and 107-108/ Ml, and fermentation is performed under anaerobic conditions at about the optimal fermentation temperature of the lactic acid bacteria used for 2 to 10 days. As the saccharide, glucose, fructose, galactose, sucrose and the like are used, and among them, fructose is most preferable. Moreover, yeast extract, malt extract, etc. may be used instead of saccharide.
[0008]
The liquid containing the fermented lactic acid bacteria of cereals obtained by the above fermentation step may be subjected to the milling step as it is, concentrated if necessary, and blended into a cosmetic or the like. The lactic acid bacteria fermented product is separated from the fermentation broth, washed with water, adjusted for water if necessary, then pulverized using a suitable pulverizing means such as mixer pulverization, roll pulverization, air pulverization, and, if necessary, drying treatment. Furthermore, the mixture is sieved and provided as an emulsifier for cosmetics and the like.
[0009]
When the emulsifier of the present invention comprising a lactic acid bacteria fermented product of cereals obtained as described above is blended or applied to cosmetics or the like, the fermented product alone has sufficient emulsifying power, and the obtained emulsified product is Although the emulsion stability is satisfactory enough for practical use, the stability of the emulsion can be further improved by further using a thickener in combination with the fermented product.
[0010]
As the thickener, those commonly used in cosmetics and the like can be used. Specifically, for example, components derived from brown algae, green algae or red algae such as alginic acid, agar, carrageenan, fucoidan; pectin; Polysaccharides such as locust bean gum; gums such as xanthan gum, tragacanth gum, and guar gum; cellulose derivatives such as carboxymethylcellulose and hydroxyethylcellulose; and high synthetic levels such as polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, and acrylic acid / methacrylic acid copolymer. Molecules; hyaluronic acid or a derivative thereof, polyglutamic acid or a derivative thereof, and the like.
Among them, from the viewpoint of emulsification stability, and further from the viewpoint of not impairing the high biosafety characteristic of the fermented product of lactic acid bacteria of the present invention, in particular, hyaluronic acid or a derivative thereof, polyglutamic acid or a derivative thereof, xanthan gum or tragacanth gum It is also preferable to use components derived from brown algae, green algae or red algae such as alginic acid, agar, carrageenan, fucoidan and the like.
[0011]
When these thickeners are used in combination, the amount used varies depending on the type of thickener used, but generally ranges from 1 to 100 parts by weight of solids per 100 parts by weight of solids of lactic acid bacteria fermented product. It is preferably in the range of 5 to 50 parts by weight, and from such a range, an optimum one is selected in consideration of the use of the emulsion, required performance, and the like.
[0012]
When used in combination with the lactic acid bacteria fermentation product, the thickener may be used by mixing it with the lactic acid bacteria fermentation product in a predetermined ratio in advance, or when emulsifying cosmetics or the like using the lactic acid bacteria fermentation product, It may be added to the emulsification system before or after the addition, or simultaneously with the fermented product. In some cases, it can be added after emulsification.
[0013]
The emulsifier comprising the fermented product of cereals of the cereals of the present invention is provided with a good emulsifying action, provides an emulsion with high stability, and is excellent in safety to the human body such as low toxicity and extremely little irritation to the skin, It is useful for preparing emulsions in a wide variety of fields such as cosmetics and external medicines, as well as foods and agricultural chemicals.
Above all, when used as an emulsifier for cosmetics or external medicines, the resulting lactobacillus fermented product has an extremely high texture and feel on the skin due to the high water retention / moisture retention and adhesiveness to the skin. There is also the advantage of being good.
Therefore, according to the present invention, there are provided cosmetics and external medicines containing the fermented lactic acid bacteria of the above-mentioned cereals, and having excellent emulsification stability and biosafety as well as excellent feeling in use.
[0014]
Examples of the cosmetics of the present invention comprising a fermented product of lactic acid bacteria of cereals include basic cosmetics such as milky lotions, creams, lotions, essences, and packs; makeup cosmetics such as lipsticks, foundations, liquid foundations, and makeup press powders Cleansing cosmetics such as facial cleansers, shampoos, and rinses; hair cosmetics such as hair treatments, conditioners, hair creams, hair dyes, and hair styling products; oral cosmetics such as toothpastes and mouthwashes; Foreign goods and the like.
In addition, examples of the external medicine of the present invention comprising a fermented product of lactic acid bacteria of cereals include creams, emulsions, and lotions.
[0015]
The amount of the fermented lactic acid bacteria of the cereals of the present invention when blended in cosmetics varies depending on the type of cosmetics and the like.For example, in the case of basic cosmetics, makeup cosmetics, hair cosmetics and quasi-drugs, If present, it is generally in the range of 0.5 to 20% by weight (as solid content of lactic acid bacteria fermented product; the same applies hereinafter), preferably in the range of 2 to 10% by weight. It is preferably in the range of 5 to 20% by weight, and in the case of oral cosmetics generally in the range of 0.5 to 20% by weight, preferably 2 to 10% by weight.
The amount of the compound to be applied to an external medicine is generally in the range of 0.5 to 20% by weight, preferably 2 to 10% by weight in the case of a cream, an emulsion or a lotion.
If a thickener is used in combination when blending the lactic acid bacteria fermentation product, the blending amount of the lactic acid bacteria fermentation product can be reduced to 40 to 80% of that in the case of the above single use.
[0016]
In addition, when the fermented product of lactic acid bacteria of the cereals of the present invention is blended into cosmetics or the like, when the fermented product of lactic acid bacteria is preliminarily mixed with one or more kinds selected from hydrophilic substances, particularly saccharides and glycols, The familiarity and dispersibility of the fermented product of lactic acid bacteria in water is improved, and it is preferred because it can be easily incorporated into cosmetics and the like.
[0017]
In this case, the saccharides include, for example, monosaccharides such as glucose, fructose, arabinose, and galactose; disaccharides such as sucrose, lactose, maltose, and trehalose; oligosaccharides such as fructooligosaccharides, xylo-oligosaccharides, and maltooligosaccharides; Sugar alcohols such as xylitol can be used.
[0018]
Examples of the glycols include glycerin, propylene glycol, 1,3-butylene glycol, and polyethylene glycol.
[0019]
Among these saccharides and / or glycols (hereinafter sometimes referred to as admixture components), use of saccharides is preferred from the viewpoint of the effect of improving the familiarity and dispersibility of the fermented product of lactic acid bacteria with water, and among the saccharides, Most preferred is the use of alcohols. .
[0020]
The effect of improving dispersibility is more effectively exhibited when the admixture of fermented lactic acid bacteria and saccharides and / or glycols is in a wet state with water or a liquid substance. When used, the resulting mixture is brought into a wet state having a moisture content in the range of 10 to 40% by weight, particularly 15 to 30% by weight, for example, by blending them with the lactic acid bacteria fermentation product in the form of an aqueous solution. Is preferred.
On the other hand, when using glycols such as glycerin and 1,3-butylene glycol which are liquid at normal temperature, it is possible to make the admixture wet based on the properties of the glycol itself, and water is not used. Although not necessary, these may be used in some cases.
[0021]
The amount of the saccharide or glycol added to the fermented lactic acid bacteria is generally 5 to 50 parts by weight, preferably 10 to 40 parts by weight, based on 100 parts by weight of the fermented lactic acid bacteria (solids). It is in the range of parts by weight.
[0022]
As a method for preparing a mixture of a fermented product of lactic acid bacteria and sugars and / or glycols, a method in which a predetermined amount of a mixed component is added to the fermented product of lactic acid bacteria and a uniform mixture is produced by using an appropriate mixing means, is commonly used. The method is not particularly limited as long as it is carried out according to the method, but when a solid substance such as a monosaccharide or a sugar alcohol is used at room temperature as an admixture component, the above-described method is used in order to more effectively exhibit the effect of improving the dispersibility of the admixture. As described above, the water content of the lactobacillus fermentation product is adjusted to a desired value by mixing the lactobacillus fermentation product with the lactobacillus fermentation product in the form of an aqueous solution, or, in some cases, mixing the powdered powder and adding water. Is preferred.
[0023]
When blending the mixture obtained as described above into cosmetics, etc., it is already known that as a result of improving the familiarity and dispersibility in water, the blending workability and the homogeneity of the obtained product are significantly improved. As described above, the lactic acid bacteria fermented product of the cereals of the present invention shows acidity when dispersed and dissolved in water due to the characteristics of lactic acid bacteria fermentation. In some cases, a summation process is required.
An alkaline substance may be further added to the mixture in order to eliminate the complexity of the process and to obtain a mixture having improved workability and handleability.
[0024]
In this case, examples of the alkaline substance include hydroxides of alkali metals or alkaline earth metals such as sodium hydroxide, potassium hydroxide, calcium hydroxide and magnesium hydroxide; alkalis of weak acids such as carbonic acid, citric acid and phosphoric acid Metal salts; amines such as ethanolamine, diethanolamine, triethanolamine and isopropanolamine; basic amino acids such as arginine, lysine and histidine; ammonia water, aminomethylpropanol and aminomethylpropanediol.
[0025]
The amount of the alkaline substance varies depending on the kind of the alkaline substance to be used and the like, but is generally such an amount that the pH of a 10% by weight aqueous dispersion or aqueous solution of the composition is in the range of 5.5 to 7.5. It is better to do.
[0026]
When preparing a cosmetic or a topical medicine containing the fermented product of cereals of the cereals of the present invention, as a component thereof, components usually used in cosmetics and the like, for example, oil components, humectants, thickeners, antiseptic, A bactericide, a powder component, an ultraviolet absorber, an antioxidant, a dye, a fragrance, a physiologically active ingredient, a drug, and the like can be appropriately used. If necessary, a surfactant may be used in combination.
[0027]
Here, as the oily component, for example, olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, coconut oil, palm oil, cocoa oil, meadowfoam oil, shea butter, tea tree oil, avocado oil, Plant-derived fats and oils such as macadamia nut oil and plant-derived squalane; animal-derived fats and oils such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax and lanolin; liquid paraffin, vaseline, paraffin wax, squalane and the like Hydrocarbons; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, stearyl alcohol; isopropyl myristate, palmitic acid Isopropyl, ole Butyl phosphate, 2-ethylhexyl glycerides, higher fatty acid octyldodecyl (octyl stearate dodecyl and the like), and the synthetic esters and synthetic triglycerides such like.
[0028]
Examples of the humectant include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidonecarboxylate, and the like, and sugars such as trehalose, lactic acid bacteria-fermented rice, hyaluronic acid, and the like. Derivatives, NMF-related substances, lactic acid, urea, higher fatty acid octyldodecyl, sea buckwheat extract, seaweed extract, seafood-derived collagen and its derivatives, various amino acids and their derivatives.
[0029]
Examples of the thickener include alginic acid, agar, carrageenan, brown alga such as fucoidan, components derived from green algae or red algae, syrup extract, pectin, locust bean gum, polysaccharides such as aloe polysaccharide, xanthan gum, tragacanth gum, guar gum and the like. Gums, cellulose derivatives such as carboxymethylcellulose, hydroxyethylcellulose, synthetic polymers such as polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic acid / methacrylic acid copolymer; hyaluronic acid and its derivatives, polyglutamic acid and its derivatives Is mentioned.
[0030]
Examples of preservatives and disinfectants include urea; paraoxybenzoic acid esters such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophen, hexachlorophen, chlorhexidine hydrochloride, benzal chloride Examples include ruconium, salicylic acid, ethanol, undecylenic acid, phenols, jamal (imidazodeinyl urea), 1,2-pentanediol, various essential oils, and bark dry distillate.
[0031]
Examples of the powder component include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, silk powder, cereals (rice, There are powders of wheat, corn, millet, etc.) and powders of legumes (soybeans, red beans, etc.).
[0032]
Examples of the ultraviolet absorbent include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, and 2-hydroxy-4. -Methoxybenzophenone-5-sulfonate, 4-tert-butyl-4-methoxybenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. .
[0033]
Examples of the antioxidant include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and its derivatives, various polyphenols, sunflower extract, rice extract and the like.
[0034]
Examples of the physiologically active components include, as whitening components, t-cycloamino acid derivatives, kojic acid and its derivatives, ascorbic acid and its derivatives, arbutin and its derivatives, ellagic acid and its derivatives, resorcinol derivatives, soybean extract, and saxifrage extract , Rice bran extract, hydrolyzate of rice bran extract, hydrolysed extract of white mustard, seagrass extract, seaweed extract such as kelp, seaweed extract such as eelgrass, linoleic acid and derivatives or processed products thereof (for example, Liposomal linoleic acid, etc.), 2,5-dihydroxybenzoic acid derivatives, etc. are animal or fish-derived collagen, nicotinic acid and its derivatives, glycyrrhizic acid and its derivatives (dipotassium salt, etc.) as skin aging prevention and skin roughness improving components. , T-cycloamino acid derivatives, vitamin A and derivatives thereof Vitamin E and its derivatives, allantoin, α-hydroxy acids, diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, gentian extract, licorice extract, barley extract, chamomile extract, carrot extract, aloe extract and other crude drug extract extracts, There are a hydrolyzate of rice extract, hydrolyzate of rice bran extract, fermented rice extract, extract of honeywort, extracts of seaweed such as eelgrass, and soybean extract.
[0035]
Examples of the above kojic acid derivatives include kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid esters such as kojic acid dibutyrate, kojic acid ethers, kojic acid sugar derivatives such as kojic acid glucoside, etc. However, examples of ascorbic acid derivatives include sodium L-ascorbic acid-2-phosphate, magnesium L-ascorbic acid-2-phosphate, sodium L-ascorbic acid-2-sulfate, and L-ascorbic acid-2. -Ascorbic acid ester salts such as magnesium sulfate, L-ascorbic acid-2-glucoside (2-O-α-D-glucopyranosyl-L-ascorbic acid), L-ascorbic acid-5-glucoside (5-O-α -D-glucopyranosyl-L-ascorbin Ascorbic acid sugar derivatives such as acid), acylated 6-positions of these ascorbic acid sugar derivatives (acyl group is hexanoyl group, octanoyl group, decanoyl group, etc.), L-ascorbic acid tetraisopalmitate, L-ascorbic acid tetraester L-ascorbic acid tetrafatty acid esters such as lauric acid ester and the like, resorcinol derivatives such as 4-n-butyl resorcinol and 4-isoamyl resorcinol, and 2,5-dihydroxybenzoic acid derivative such as 2,2 5-diacetoxybenzoic acid, 2-acetoxy-5-hydroxybenzoic acid, 2-hydroxy-5-propionyloxybenzoic acid, etc., as nicotinic acid derivatives, for example, nicotinamide, benzyl nicotinate, etc., as vitamin E derivatives Is, for example, Glutamic E nicotinate, vitamin E linoleate and the like, as the α- hydroxy acids such as lactic acid, malic acid, succinic acid, citric acid, α- hydroxy octanoic acid.
[0036]
Drugs include anti-inflammatory and analgesic agents such as ethyl aminobenzoate, indomethacin, sodium heparin, and methyl salicylate; anti-inflammatory agents for corticosteroids such as hydrocortisone, dexamethasone, fluocinolone acetonide, and prednisolone; benzalkonium chloride, chloride Fungicides such as benzethonium, chlorhexidine, and sulfadiazine; antibiotic fungicides such as erythromycin, tetracycline, chloramphenicol, and tricomycin; antifungal agents such as clotrimazole, tolnaftate, miconazole nitrate, ketoconazole; diphenhydramine, chlorpheniramine maleate , Isohistendyl hydrochloride, clemastine fumarate and other antihistamines; urea, salicylic acid, vitamin A, vitamin E, vitamin C, vitamin B6Skin roughness improving agents, etc.
[0037]
As described above, it is not always necessary to use the surfactant in combination, but if it is used in combination, the surfactant having excellent biosafety such as sucrose fatty acid ester, lecithin and its derivative, and enzyme-treated stevia is used. Is preferably used in a small amount.
[0038]
Next, the present invention will be described more specifically with reference to Examples, Formulation Examples (Examples of cosmetics and external medicines) and Test Examples, but the present invention is not limited thereto. In the following, all parts are parts by weight, and all parts are by weight.
[0039]
Embodiment 1 FIG. Preparation of emulsifier (1)
1 Kg of barley is immersed in 70% ethanol overnight to sterilize it, and then, after collecting the barley by filtration, adding 2 L of boil-sterilized water and washing the same three times, the ethanol is sufficiently removed. Removed.
After adding 3 L of boil-sterilized 0.1% yeast extract solution to sterilized barley, a lactic acid bacteria (S. faecalis) culture solution pre-cultured (37 ° C. for 3 days) in GYP medium was added thereto. And the concentration of lactic acid bacteria is 108An amount of 1 / 0.1% yeast extract was added, and the cells were cultured at 37 ° C. for 3 days under a nitrogen atmosphere.
After the cultivation, the lactic acid bacteria fermented product of the oats was fractionated by coarse filtration through a wire mesh, washed with running water, and the attached culture solution was sufficiently washed away. Was reduced to about 15% or less. Next, the dried product was pulverized with a mixer and then sieved (90 μm, 166 mesh) to obtain a fermented product of lactic acid bacteria of barley as a fine powder (yield 920 g, moisture content 12.5%).
[0040]
Embodiment 2. FIG. Preparation of emulsifier (2)
S. lactic acid bacteria faecalis in place of L. The same operation as in Example 1 was performed except that plantalum was used, and a fermented product of lactic acid bacteria of pigeon barley was obtained as a fine powder (yield 910 g, moisture content 12.4%).
[0041]
Embodiment 3 FIG. Preparation of emulsifier (3)
The same operation as in Example 1 was carried out except that barley was used instead of pigeon barley to obtain a fermented product of barley lactic acid bacteria as a fine powder (yield 580 g, moisture content 12.0%).
[0042]
Embodiment 4. FIG. Preparation of emulsifier (4)
The same operation as in Example 1 was carried out except that millet was used in place of pigeon barley to obtain a fermented product of millet lactic acid bacteria as a fine powder (yield 880 g, moisture content 12.8%).
[0043]
Embodiment 5 FIG. Preparation of emulsifier (5)
The same operation as in Example 1 was carried out except that millet was used in place of the pigeon wheat, to obtain a fermented product of millet lactic acid bacteria as a fine powder (yield: 890 g, moisture content: 12.4%).
[0044]
Embodiment 6 FIG. Preparation of emulsifier (6)
The same operation as in Example 1 was carried out except that barley was used instead of pigeon barley to obtain a fermented product of lactic acid bacteria of barley as a fine powder (yield 900 g, moisture content 12.0%).
[0045]
Embodiment 7 FIG. Preparation of emulsifier (7)
The same operation as in Example 1 was carried out except that soybean was used instead of pigeon barley, to obtain a fermented product of lactic acid bacteria of soybean as a fine powder (yield 920 g, moisture content 13.2%).
[0046]
Embodiment 8 FIG. Preparation of emulsifier (8)
The same operation as in Example 1 was carried out except that red bean was used instead of pigeon barley to obtain a fermented product of lactic acid bacteria of red bean as a fine powder (yield 780 g, moisture content 12.5%).
[0047]
Embodiment 9 FIG. Preparation of emulsifier (9)
The soybeans were washed with water, immersed in three times the amount of water overnight, and then drained. This was kept in a wet state at 30 ° C. for 2 days to germinate, and the germinated soybean was dried at 60 ° C. overnight.
1 Kg of the dried germinated soybeans was immersed in 70% ethanol overnight to sterilize, then the germinated soybeans were collected by filtration, and 2 L of boil-sterilized water was added thereto and washed three times. It was sufficiently removed.
To the sterilized germinated soybeans, 3 L of a boil-sterilized 0.1% yeast extract solution was added, and then lactic acid bacteria (S. faecalis) culture pre-cultured (37 ° C., 3 days) in a GYP medium was added thereto. When the concentration of lactic acid bacteria is 108An amount of 1 / 0.1% yeast extract was added, and the cells were cultured at 37 ° C. for 3 days under a nitrogen atmosphere.
After completion of the cultivation, the lactic acid bacteria fermented germinated soybeans were fractionated by coarse filtration through a wire mesh, washed with running water, and the attached culture solution was sufficiently washed away. Was reduced to about 15% or less. Next, the dried product was pulverized with a mixer and then sieved (90 μm, 166 mesh) to obtain a fermented product of germinated soybean lactic acid bacteria as a fine powder (yield: 890 g, moisture content: 13.5%).
[0048]
Embodiment 10 FIG. Preparation of emulsifier (10)
The same operation as in Example 9 was carried out except that barley was used instead of soybean to obtain a fermented product of germinated barley lactic acid bacteria as a fine powder (yield 880 g, moisture content 12.8%).
[0049]
Embodiment 11 FIG. Preparation of emulsifier composition (1)
200 g of maltitol liquid (70% maltitol aqueous solution) was added to 800 g of fine powder of fermented product of pigeon barley lactic acid bacteria obtained in the same manner as in Example 1, and the mixture was kneaded and mixed with a kneading machine to obtain uniform mixing. A product was obtained (water content: 14.6%).
[0050]
Embodiment 12 FIG. Preparation of emulsifier composition (2)
The procedure of Example 11 was repeated, except that 200 g of glycerin was used instead of 200 g of the maltitol solution, to obtain a uniform mixture (water content: 12.4%).
[0051]
Embodiment 13 FIG. Preparation of emulsifier composition (3)
200 g of maltitol solution and 15 g of arginine were added to 785 g of the fine powder of the fermented product of pigeon barley lactic acid bacteria obtained in the same manner as in Example 1 and kneaded and kneaded with a kneading machine to obtain a uniform mixture. (Water content 15.1%).
[0052]
Formulation Example 1. cream
[A component] part
Liquid paraffin 5.0
Olive oil ¥ 4.0
Paraffin $ 5.0
Cetanol 2.0
Butyl paraben 0.1
[B component]
Emulsifier of Example 1 5.0
1,3-butylene glycol 10.0
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the component C was added and mixed by stirring, and further cooled to 30 ° C. or lower to obtain a homogeneous cream.
[0053]
Formulation example 2. Latex
[A component] part
Liquid paraffin 5.0
Olive oil ¥ 4.0
Squalane $ 5.0
Butyl paraben 0.1
[B component]
Emulsifier of Example 1 5.0
1,3-butylene glycol 10.0
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the C component was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain a homogeneous emulsion.
[0054]
Formulation example 3. Lotion
[A component] part
Olive oil 1.0
Butyl paraben 0.1
[B component]
Emulsifier of Example 1 1.0
Ethanol $ 5.0
Glycerin 5.0
1,3-butylene glycol @ 5.0
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the C component was added and mixed by stirring, and further cooled to 30 ° C. or lower to obtain a milky lotion.
[0055]
Formulation Example 4. essence
[A component] part
Olive oil 1.0
Butyl paraben 0.1
[B component]
Emulsifier of Example 1 2.0
Ethanol $ 5.0
Hyaluronic acid 0.3
1,3-butylene glycol @ 5.0
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the component C was added and mixed by stirring, and further cooled to 30 ° C. or lower to obtain a milky white essence.
[0056]
Formulation Example 5. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2 except that 5.0 parts of the emulsifier of Example 1 was used in place of 5.0 parts of the emulsifier in Formulation Example 2.
[0057]
Formulation Example 6. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 1 was used instead of 5.0 parts of the emulsifier of Example 1 in the B component of Formulation Example 2.
[0058]
Formulation Example 7. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 1 was used instead of 5.0 parts of the emulsifier of Example 1 in the B component of Formulation Example 2.
[0059]
Formulation Example 8. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 1 was used instead of 5.0 parts of the emulsifier of Example 1 in the B component of Formulation Example 2.
[0060]
Formulation Example 9. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 1 was used instead of 5.0 parts of the emulsifier of Formulation 2 in the B component of Formulation Example 2.
[0061]
Formulation Example 10. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 1 was replaced with 5.0 parts of the emulsifier of Formulation Example 2.
[0062]
Formulation Example 11. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2 except that 5.0 parts of the emulsifier of Example 1 was replaced with 5.0 parts of the emulsifier of Example 8 in the B component of Formulation Example 2.
[0063]
Formulation Example 12. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 1 was used instead of 5.0 parts of the emulsifier of Example 1 in the B component of Formulation Example 2.
[0064]
Formulation Example 13. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2 except that 5.0 parts of the emulsifier of Example 1 was replaced with 5.0 parts of the emulsifier of Example 10 in the B component of Formulation Example 2.
[0065]
Formulation Example 14. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 6.0 parts of the emulsifier composition of Example 11 was used in place of 5.0 parts of the emulsifier of Example 1 in the B component of Formulation Example 2.
[0066]
Formulation Example 15. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 6.0 parts of the emulsifier composition of Example 12 was used instead of 5.0 parts of the emulsifier of Example 1 in the B component of Formulation Example 2.
[0067]
Formulation example 16. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 6.0 parts of the emulsifier composition of Example 13 was used instead of 5.0 parts of the emulsifier of Example 1 in the B component of Formulation Example 2.
[0068]
Formulation example 17. Latex
A homogeneous emulsion was prepared in the same manner as in Formulation Example 2 except that the emulsifier of Formulation Example 2 was replaced with 5.0 parts of the emulsifier of Example 1 and 2.0 parts of the emulsifier of Example 1 and 0.5 part of xanthan gum were used. Obtained.
[0069]
Formulation Example 18. Latex
A homogeneous emulsion was prepared in the same manner as in Formulation Example 2 except that 2.0 parts of the emulsifier of Example 1 and 0.5 part of hyaluronic acid were used in place of 5.0 parts of the emulsifier of Example 1 in the B component of Formulation Example 2. Got.
[0070]
Formulation Example 19. Hair Treatment
[A component] part
Stearyl trimethyl ammonium chloride 5.0
Glyceryl monostearate 1.0
Cetanol 3.0
Octyldodecanol 2.0
[B component]
Emulsifier of Example 1 5.0
1,3-butylene glycol @ 5.0
Hydrolyzed collagen powder 0.5
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the component C was added, mixed with stirring, and further cooled to 30 ° C. or lower.
[0071]
Formulation example 20. Hair cream
[A component] part
Squalane $ 15.0
Vaseline $ 15.0
Beeswax 2.0
Methyl paraben appropriate dosage
[B component]
Glycerin @ 3.0
1,3-butylene glycol @ 3.0
Xanthan gum 0.1
Emulsifier of Example 2 5.0
Polyoxyethylene hydrogenated castor oil 3.0
Purified water = amount of 100 parts
[C component]
Appropriate amount of fragrance
After the components A and B were each heated and dissolved at 80 ° C., the two components were combined and homogenized with a Hiscotron (5000 rpm) for 2 minutes. This was cooled with stirring, and the C component was added at 50 ° C., and further cooled to 30 ° C.
[0072]
Formulation Example 21. Hair dye / Dye base
[A component] part
Oxidation dye 3.5
Oleic acid 20.0
Stearic acid diethanolamide 3.0
Polyoxyethylene (50) oleyl ether 1.0
[B component]
Emulsifier of Example 3 3.0
1,3-butylene glycol 10.0
Isopropanol 10.0
Ammonia water (28%) 10.0
Sodium sulfite 0.5
Purified water = amount of 100 parts
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
This was cooled to 30 ° C. or lower while stirring.
[0073]
Formulation Example 22. Liquid Foundation
[A component] part
Stearic acid 2.5
Cetanol 0.5
Glyceryl monostearate 2.0
Lanolin 2.0
Squalane $ 3.0
Isopropyl myristate @ 8.0
Propyl paraben 0.1
[B component]
Emulsifier of Example 1 3.0
Xanthan gum 0.3
1,3-butylene glycol @ 5.0
Triethanolamine 1.0
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Titanium oxide 8.0
Talc $ 4.0
Color pigment appropriate amount
[D component]
Fragrance 0.3
The C component was mixed and pulverized with a pulverizer. The B component was mixed, and the pulverized C component was added thereto, and the mixture was uniformly dispersed in a colloid mill. After heating the A component and the uniformly dispersed B and C components to 80 ° C., respectively, the A component was added to the B and C components while stirring, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes. After cooling to 50 ° C., the D component was added and mixed with stirring, and further cooled to 30 ° C. or lower with further stirring.
[0074]
Formulation Example 23. Cream foundation
[A component] part
Stearic acid $ 5.0
Cetanol 2.0
Glyceryl monostearate 3.0
Liquid paraffin 5.0
Squalane $ 3.0
Isopropyl myristate @ 8.0
Propyl paraben 0.1
[B component]
Emulsifier of Example 553.0
Sorbitol 3.0
1,3-butylene glycol @ 5.0
Triethanolamine 1.5
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Titanium oxide 8.0
Talc 2.0
Kaolin 5.0
Bentonite 1.0
Color pigment appropriate amount
[D component]
Fragrance 0.3
The C component was mixed and pulverized with a pulverizer. The B component was mixed, and the pulverized C component was added thereto, and the mixture was uniformly dispersed in a colloid mill. After heating the A component and the uniformly dispersed B and C components to 80 ° C., respectively, the A component was added to the B and C components while stirring, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes. After cooling to 50 ° C., the D component was added and mixed with stirring, and further cooled to 30 ° C. or lower with further stirring.
[0075]
Formulation Example 24. Cream rinse
[A component] part
Polyoxyethylene (10) hydrogenated castor oil 1.0
Distearyl dimethyl ammonium chloride 塩 化 1.5
Stearyl trimethyl ammonium chloride 2.0
Glyceryl 2-ethylhexanoate 1.0
Cetanol @ 3.2
Stearyl alcohol 1.0
Methyl paraben 0.1
[B component]
Emulsifier of Example 1 # 15.0
1,3-butylene glycol @ 5.0
Purified water = amount of 100 parts
The components A and B were each heated to 80 ° C. and uniformly dissolved, and then the component B was added to the component A, and the mixture was stirred and cooled to room temperature.
[0076]
Formulation example 25. Cream shampoo
[A component] part
Sodium N-coconut fatty acid methyltaurine 10.0
Sodium polyoxyethylene (3) alkyl ether sulfate 20.0
Betaine lauryl dimethylaminoacetate 10.0
Coconut oil fatty acid diethanolamide 4.0
Methyl paraben 0.1
[B component]
Citric acid 0.1
Emulsifier of Example 6 # 15.0
1,3-butylene glycol 2.0
Purified water = amount of 100 parts
The components A and B were each heated to 80 ° C. and uniformly dissolved, and then the component B was added to the component A, and the mixture was stirred and cooled to room temperature.
[0077]
Formulation Example 26. Body shampoo
[A component] part
N-lauroylmethylalanine sodium 25.0
Coconut oil fatty acid potassium solution (40%) @ 26.0
Coconut oil fatty acid diethanolamide 3.0
Methyl paraben 0.1
[B component]
Emulsifier of Example 1 10.0
1,3-butylene glycol 2.0
Purified water = amount of 100 parts
The components A and B were each heated to 80 ° C. and uniformly dissolved, and then the component B was added to the component A, and the mixture was stirred and cooled to room temperature.
[0078]
Formulation example 27. Toothpaste
[A component] part
Dibasic calcium phosphate dihydrate ¥ 60.0
Silicic anhydride 2.0
Appropriate amount of fragrance
[B component]
Glycerin 10.0
1,3-butylene glycol @ 5.0
Emulsifier of Example 8 # 5.0
Sodium lauryl sulfate 2.0
Carrageenan 0.3
Methyl paraben appropriate dosage
Saccharin sodium 0.1
Purified water = amount of 100 parts
The component B was mixed, heated and dissolved at 80 ° C, and then cooled to 30 ° C. After the component A was added thereto and kneaded sufficiently, the mixture was defoamed under reduced pressure.
[0079]
Formulation Example 28. Latex
[A component] part
Liquid paraffin 5.0
Olive oil ¥ 4.0
Squalane $ 5.0
Butyl paraben 0.1
[B component]
Emulsifier of Example 1 5.0
1,3-butylene glycol 10.0
Kojic acid 2.0
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the C component was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain a homogeneous emulsion.
[0080]
Formulation Example 29. Latex
In the B component of Formulation Example 28, an emulsion was prepared in the same manner as in Formulation Example 28 except that 2.0 parts of L-ascorbic acid-2-glucoside and 0.2 part of potassium hydroxide were used instead of 2.0 parts of kojic acid. Obtained.
[0081]
Formulation example 30. Latex
An emulsion was obtained in the same manner as in Formulation Example 28 except that 3.0 parts of magnesium L-ascorbic acid-2-phosphate was used in place of 2.0 parts of kojic acid in Component B of Formulation Example 28.
[0082]
Formulation Example 31. Latex
An emulsion was obtained in the same manner as in Preparation Example 28 except that 2.0 parts of arbutin was used instead of 2.0 parts of kojic acid in the B component of Preparation Example 28.
[0083]
Formulation example 32. Latex
[A component] part
Liquid paraffin 5.0
Olive oil ¥ 4.0
Squalane $ 5.0
Diisopropylamine dichloroacetate 0.5
Butyl paraben 0.1
[B component]
Emulsifier of Example 3 3.0
1,3-butylene glycol 10.0
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the component C was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain an emulsion.
[0084]
Formulation Example 33. Latex
[A component] part
Liquid paraffin 5.0
Olive oil ¥ 4.0
Squalane $ 5.0
γ-amino-β-hydroxybutyric acid 0.5
Butyl paraben 0.1
[B component]
Emulsifier of Example 2 3.0
1,3-butylene glycol 10.0
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the C component was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain a homogeneous emulsion.
[0085]
Formulation Example 34. Bath salt
[A component] part
Ethanol $ 5.0
Methyl paraben 0.2
Yellow No. 4 $ 0.1
Fragrance 1.5
[B component]
1,3-butylene glycol @ 5.0
Emulsifier of Example 1 10.0
Purified water = amount of 100 parts
[C component]
Disodium hydrogen phosphate qs
After the component B was heated to 85 ° C. to dissolve it and cooled to room temperature, a solution prepared by mixing and dissolving the component A was added thereto, and then the component C was added to adjust the pH to 7.
[0086]
Formulation Example 35. Antiphlogistic analgesic
[A component] part
Liquid paraffin 5.0
Olive oil ¥ 4.0
Paraffin $ 5.0
Cetanol 2.0
Indomethacin 1.0
Butyl paraben 0.1
[B component]
Emulsifier of Example 1 5.0
1,3-butylene glycol 10.0
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the component C was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain an anti-inflammatory analgesic (cream).
[0087]
Formulation Example 36. Anti-inflammatory
[A component] part
Liquid paraffin 5.0
Olive oil ¥ 4.0
Paraffin $ 5.0
Cetanol 2.0
Dexamethasone 0.2
Butyl paraben 0.1
[B component]
Emulsifier of Example 1 5.0
1,3-butylene glycol 10.0
Methyl paraben 0.1
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the component C was added and mixed by stirring, and further cooled to 30 ° C. or lower to obtain an anti-inflammatory agent (cream).
[0088]
Formulation Example 37. Antifungal agent
[A component] part
Liquid paraffin 5.0
Olive oil ¥ 4.0
Squalane $ 5.0
Tolnaftate 1.0
Butyl paraben 0.1
[B component]
Emulsifier of Example 2 3.0
1,3-butylene glycol 10.0
Purified water = amount of 100 parts
[C component]
Fragrance 0.3
The components A and B were each heated to 80 ° C. or higher, and then the components A and B were added and stirred, and further homogenized with a Hiscotron (5000 rpm) for 2 minutes.
After cooling to 50 ° C., the C component was added and mixed by stirring, and further cooled to 30 ° C. or lower to obtain an antifungal agent (emulsion).
[0089]
Test Example 1 Emulsifying action (1)
The emulsifier of the lactic acid bacteria fermentation product of the cereals of the present invention and the fine powder obtained by crushing the cereals with a mixer and sieving them (90 μm, 166 mesh) for comparison were examined for emulsifying action.
[sample]
(1) Sample of the present invention: each emulsifier of Examples 1, 3, 4, 5, 6, 7 and 8
(2) Comparative sample: fine powder of pigeon barley, barley, millet, millet, millet, soybean and red bean
[Test method]
Emulsions having the component compositions shown in Table 1 were prepared, and the state immediately after the emulsification and changes over time were observed. In addition, the composition A of Table 1 was used for the emulsifiers of Examples 7 and 8, and the fine powder of soybeans and red beans, and the composition B was used for the other samples.
[0090]
[Table 1]
Figure 2004137196
[0091]
That is, the component 4 was dissolved in the component 3, the components 2 and 5 were added thereto, mixed, and heated to 80 ° C. This was added to the oily component of Component 1 heated at 80 ° C., homogenized under the condition of 5000 rpm × 2 minutes, and then cooled with water with stirring to room temperature. Each of the obtained emulsions was placed in a 50-ml screw bottle, and the emulsified state immediately after preparation and the time-dependent change in the emulsified state when stored at room temperature or 50 ° C. for 3 months were visually observed, and evaluated according to the following criteria. did.
◎: good
○: Slight separation is observed after more than one month
Δ: Slight separation is observed after 2 weeks to 1 month
×: Completely separated within one week
In addition, in the case of the comparative samples of the fine powder of barley, fine millet, and fine powder of soybean, oil floating was observed immediately after preparation of the emulsion, and the emulsified state was poor.
[0092]
[result]
Table 2 shows the results.
[Table 2]
Figure 2004137196
[0093]
As shown in Table 2, the emulsifiers comprising the fermented lactic acid bacteria of cereals of the present invention all have excellent emulsifying action and give stable emulsions for a long period of time. On the other hand, a stable emulsion cannot be obtained depending on the fine powder of cereals not subjected to lactic acid bacteria fermentation.
[0094]
Test Example 2. Emulsifying action (2)
The effect on the emulsion stability when a thickener was used in combination with the fermented lactic acid bacteria was investigated.
[Test method]
Three types of emulsions having the component compositions (units: parts) shown in Table 3 were prepared, and their changes over time were observed.
[0095]
[Table 3]
Figure 2004137196
[0096]
That is, the component 4 was dissolved in the component 3, and one of the components 5 was added thereto and mixed. Separately, the mixture of components 2 and 6 and component 1 were each heated to 80 ° C., and then the mixture of components 2 and 6 was added to component 1 and homogenized with a Hiscotron (5000 rpm) for 2 minutes. A mixture of the above components 3, 4, and 5 was added thereto, and the mixture was further homogenized with Hiscotron (5000 rpm) for 1 minute, and then cooled to room temperature with stirring. Each of the obtained emulsions was placed in a 50 ml screw bottle, and the emulsified state immediately after preparation and the time-dependent change in the emulsified state when stored at room temperature or 50 ° C. for 3 months were visually observed, and the same as in Test Example 1. Was evaluated according to the criteria of
[0097]
[result]
Table 4 shows the results.
[Table 4]
Figure 2004137196
[0098]
From the results in Table 4, it can be seen that when a thickener is used in combination with the fermented lactic acid bacteria, the stability of the obtained emulsion is further improved.
[0099]
Test Example 3 Skin irritation
The skin irritation of the fermented product of lactic acid bacteria of the present invention was compared with that of a component commonly used as an emulsifier for cosmetics.
[sample]
The following components were kneaded with Japanese Pharmacopoeia to obtain a 5% concentration of hydrophilic petrolatum and used as a sample.
(1) Emulsifier of Example 1 (sample of the present invention)
(2) polyoxyethylene (20) sorbitan monooleate (comparative sample a)
(3) Lipophilic glyceryl monostearate (Comparative sample b)
[0100]
[Test method]
Five adult males aged 20 to 50 years were taken as subjects, and the inside of each upper arm was wiped with ethanol to remove sebum, and 0.2 g of each sample was applied to the aluminum plate of the fin chamber. Affixed. Twenty-four hours later, the fin chamber was removed, and the degree of skin irritation was determined by the following method and criteria.
[0101]
[Judgment]
At 1 hour, 24 hours and 48 hours after the patch removal, the erythema and edema at the application site were visually determined based on the following “Skin irritation evaluation criteria by Draize method”, and the average value of 5 subjects was determined. I asked.
(Erythema)
Score Skin condition
0: No erythema
1: Very mild erythema
2: Evident erythema
3: Medium to strong erythema
4 : Crimson erythema and light crust formation
(edema)
Score Skin condition
0: No edema
1: Very mild edema
2: Empty edema (clearly distinguishable from surroundings)
3: Medium edema (1mm or more swelling)
4: Strong edema (spread to surrounding area)
[0102]
[result]
Table 5 shows the results.
[Table 5]
Figure 2004137196
[0103]
The activators a and b used as comparative samples in this test are widely used for emulsification of cosmetics because of their relatively high safety. Emulsifiers composed of fermented lactic acid bacteria have less skin irritation than those emulsifiers and are extremely excellent in safety.
[0104]
Test Example 4. Monitor test
For each of the following samples, the usability and safety (skin irritation) were evaluated by a monitor test.
[sample]
(1) Emulsion of Formulation Example 2 (Emulsion of the present invention)
(2) In Formulation Example 2, it was obtained in the same manner as in Formulation Example 2 except that 2.0 parts of polyoxyethylene (20) sorbitan monooleate was used instead of 5.0 parts of the emulsifier of Example 1. Latex (comparative latex)
[0105]
[Test method]
The subjects were 20 randomly selected females aged 18 to 50 years of age. Each emulsion was applied twice a day (morning and evening) to the left upper arm for 5 days. The following items were evaluated.
(Usability)
I. Feeling picked up
B. Elongation during application
C. Smoothness during application
D. Permeability (feeling of penetration)
E. Feel after application
(Skin irritation)
F. Irritation during application
G. Irritation after application
The evaluation was based on a five-point scale (A: good, B: somewhat good, C: normal, D: slightly poor, E: bad) for the feeling of use, and a three-point scale for skin irritation (A: no irritation, B: discomfort, C: irritation).
[0106]
[result]
The results are shown in Tables 6 and 7.
[Table 6]
Figure 2004137196
[0107]
[Table 7]
Figure 2004137196
[0108]
As shown in Tables 6 and 7, the emulsion prepared using the emulsifier comprising the fermented product of lactic acid bacteria of the present invention was highly evaluated in terms of feeling of use, and no skin irritation was observed.
On the other hand, the comparative emulsion obtained using the synthetic surfactant was not only inferior in the feeling of use but also showed some skin irritation.
【The invention's effect】
The emulsifier of the present invention comprising fermented lactic acid bacteria of cereals has excellent emulsifying power, is excellent in safety to humans such as low toxicity and extremely little skin irritation, and is widely used in cosmetics, external medicines, foods and the like. Useful for preparing emulsions in the field. Above all, when used as an emulsifier for cosmetics and topical medicines, the resulting cosmetics and topical medicines have a feeling and use on the skin because of the high moisturizing and water-retaining ability of the fermented lactic acid bacterium and the adhesiveness to the skin. It will be a good feeling.
Therefore, according to the present invention, there are also provided cosmetics and external medicines comprising the above-mentioned fermented product of lactic acid bacteria and having good emulsification stability and biosafety, as well as good feeling upon use.

Claims (6)

雑穀類の一種又は二種以上を乳酸菌で醗酵させて得られる乳酸菌醗酵物からなる乳化剤。An emulsifier comprising a fermented product of lactic acid bacteria obtained by fermenting one or more kinds of cereals with lactic acid bacteria. 雑穀類として、麦類、豆類及び雑穀から選ばれた一種又は二種以上を用いる請求項1に記載の乳化剤。The emulsifier according to claim 1, wherein one or more selected from wheat, beans, and millet are used as the millet. 麦類が、大麦、小麦、及びハト麦から選ばれたものである請求項2に記載の乳化剤。The emulsifier according to claim 2, wherein the barley is selected from barley, wheat, and barley. 豆類が、大豆及び小豆から選ばれたものである請求項2に記載の乳化剤。The emulsifier according to claim 2, wherein the beans are selected from soybeans and red beans. 雑穀が、アワ、キビ、ヒエ及びトウモロコシから選ばれたものである請求項2に記載の乳化剤。The emulsifier according to claim 2, wherein the millet is selected from millet, millet, millet, and corn. 雑穀類の一種又は二種以上を乳酸菌で醗酵させて得られる乳酸菌醗酵物を配合してなる化粧料又は外用医薬品。A cosmetic or topical medicine comprising a fermented lactic acid bacterium obtained by fermenting one or more cereals with lactic acid bacteria.
JP2002302998A 2002-10-17 2002-10-17 Emulsifiers and cosmetics Expired - Lifetime JP4674286B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002302998A JP4674286B2 (en) 2002-10-17 2002-10-17 Emulsifiers and cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002302998A JP4674286B2 (en) 2002-10-17 2002-10-17 Emulsifiers and cosmetics

Publications (2)

Publication Number Publication Date
JP2004137196A true JP2004137196A (en) 2004-05-13
JP4674286B2 JP4674286B2 (en) 2011-04-20

Family

ID=32450909

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002302998A Expired - Lifetime JP4674286B2 (en) 2002-10-17 2002-10-17 Emulsifiers and cosmetics

Country Status (1)

Country Link
JP (1) JP4674286B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007145790A (en) * 2005-03-07 2007-06-14 Kyoei Kagaku Kogyo Kk Cosmetic
JP2007290998A (en) * 2006-04-24 2007-11-08 Morishita Jintan Kk Sprouted adlay fermentation-treated product
JP2008545003A (en) * 2005-06-29 2008-12-11 クエスト・インターナショナル・サービシーズ・ビー・ブイ Improvements in skin or hair care
KR101242442B1 (en) 2011-06-21 2013-03-12 주식회사 마크로케어 Cosmetic Composition Comprising Extracts of Fermented Setaria italica
JP2013116086A (en) * 2011-12-05 2013-06-13 Taiyo Corp Germinated soybean fermented composition
KR101449282B1 (en) 2013-05-14 2014-10-08 가천대학교 산학협력단 Composition for improving skin wrinkle and skin moisturing comprising Barley fermented by Pichia jadinii and Aureobasidium pullulans bacteria
KR102111058B1 (en) * 2019-07-02 2020-05-15 주식회사 아미코스메틱 A cosmetic composition for skin moisturizing comprising an extract of plant-derived lactobacillus brevis (ami-1109) femented barley
CN111467286A (en) * 2020-05-15 2020-07-31 万京创科(山东)生物科技有限公司 Millet compound fermentation product and preparation method and application thereof
KR102226131B1 (en) * 2020-10-30 2021-03-10 주식회사 하이솔 Composition for skin moisturizing comprising extract of fermented Setaria italica as effective component
JP2022507139A (en) * 2018-11-12 2022-01-18 株式会社 資生堂 External skin composition

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007145790A (en) * 2005-03-07 2007-06-14 Kyoei Kagaku Kogyo Kk Cosmetic
JP4693623B2 (en) * 2005-03-07 2011-06-01 共栄化学工業株式会社 Cosmetics
JP2008545003A (en) * 2005-06-29 2008-12-11 クエスト・インターナショナル・サービシーズ・ビー・ブイ Improvements in skin or hair care
JP2007290998A (en) * 2006-04-24 2007-11-08 Morishita Jintan Kk Sprouted adlay fermentation-treated product
KR101242442B1 (en) 2011-06-21 2013-03-12 주식회사 마크로케어 Cosmetic Composition Comprising Extracts of Fermented Setaria italica
JP2013116086A (en) * 2011-12-05 2013-06-13 Taiyo Corp Germinated soybean fermented composition
KR101449282B1 (en) 2013-05-14 2014-10-08 가천대학교 산학협력단 Composition for improving skin wrinkle and skin moisturing comprising Barley fermented by Pichia jadinii and Aureobasidium pullulans bacteria
JP2022507139A (en) * 2018-11-12 2022-01-18 株式会社 資生堂 External skin composition
JP7350067B2 (en) 2018-11-12 2023-09-25 株式会社 資生堂 Skin external preparation composition
KR102111058B1 (en) * 2019-07-02 2020-05-15 주식회사 아미코스메틱 A cosmetic composition for skin moisturizing comprising an extract of plant-derived lactobacillus brevis (ami-1109) femented barley
CN111467286A (en) * 2020-05-15 2020-07-31 万京创科(山东)生物科技有限公司 Millet compound fermentation product and preparation method and application thereof
KR102226131B1 (en) * 2020-10-30 2021-03-10 주식회사 하이솔 Composition for skin moisturizing comprising extract of fermented Setaria italica as effective component

Also Published As

Publication number Publication date
JP4674286B2 (en) 2011-04-20

Similar Documents

Publication Publication Date Title
US8071115B2 (en) Cosmetics
KR101217382B1 (en) EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF α,α-TREHALOSE
JP4734093B2 (en) Cosmetics
JP5129440B2 (en) Fermented plant and cosmetics containing the same
JP6599607B2 (en) Antioxidants, skin cosmetics and hair cosmetics
JP4495925B2 (en) Collagen and elastin production promoter and anti-aging cosmetic containing the same
JP4674286B2 (en) Emulsifiers and cosmetics
JP5649284B2 (en) Emulsifiers and cosmetics
JP4769153B2 (en) Cosmetics
JP4500906B2 (en) Cosmetic compounding agent and cosmetics containing the same
JP5900915B2 (en) Whitening cosmetics
JP2001212445A (en) Emulsifying agent
JP2004097999A (en) Emulsifier and cosmetic
JP2016166141A (en) Cosmetics
JP6362836B2 (en) emulsifier
JP3987733B2 (en) Fibroblast activator and skin external preparation containing the same
JP2021185879A (en) Yeast culture extract and skin preparation containing the same
JP4621958B2 (en) Cosmetic compounding agent and cosmetics containing the same
JP2019069919A (en) Gelatinous composition
JP2022030982A (en) External preparation for skin
JP2022126232A (en) Processed yeast and external preparation for skin
JP2023134261A (en) Carbonylation inhibitor and cytokine production inhibitor
JP2023024185A (en) External composition for skin and composition for eating and drinking
JP2022124741A (en) External preparation for skin

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051013

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20061215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070312

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070508

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101105

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140204

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4674286

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term